ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Gland Pharma Limited granted 5,90,249 employee stock options to 124 employees under its ESOP 2025 scheme. These options are subject to specified vesting schedules and pricing.
Gland Pharma Limited announced the grant of 16,790 employee stock options to 3 employees under the Gland Pharma Employee Stock Option Scheme 2025.
Gland Pharma allotted 2,03,259 equity shares following the exercise of employee stock options. This issuance raised approximately ₹1.04 Crore and increased the total paid-up share capital.
Gland Pharma convened an ESOP Compensation Committee meeting for May 15, 2026. The committee will consider granting stock options under its 2025 employee incentive scheme.